| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1018930220 |
| P356 | DOI | 10.1186/2044-5040-1-10 |
| P932 | PMC publication ID | 3156633 |
| P698 | PubMed publication ID | 21798087 |
| P5875 | ResearchGate publication ID | 51529520 |
| P50 | author | Renzhi Han | Q57020595 |
| P2093 | author name string | Renzhi Han | |
| P2860 | cites work | Calcium-sensitive phospholipid binding properties of normal and mutant ferlin C2 domains | Q24294673 |
| Affixin activates Rac1 via betaPIX in C2C12 myoblast | Q24321686 | ||
| AHNAK, a novel component of the dysferlin protein complex, redistributes to the cytoplasm with dysferlin during skeletal muscle regeneration | Q24337859 | ||
| Membrane fusion: grappling with SNARE and SM proteins | Q24633113 | ||
| Affixin interacts with alpha-actinin and mediates integrin signaling for reorganization of F-actin induced by initial cell-substrate interaction | Q24676556 | ||
| Release of chromatin protein HMGB1 by necrotic cells triggers inflammation | Q28131815 | ||
| Defective membrane repair in dysferlin-deficient muscular dystrophy | Q28203095 | ||
| Dysferlin Interacts with Annexins A1 and A2 and Mediates Sarcolemmal Wound-healing | Q28204713 | ||
| Muscle inflammation and MHC class I up-regulation in muscular dystrophy with lack of dysferlin: an immunopathological study | Q28205102 | ||
| Complement. First of two parts | Q28210663 | ||
| Complement. Second of two parts | Q28211878 | ||
| Characterization of lipid binding specificities of dysferlin C2 domains reveals novel interactions with phosphoinositides | Q28236858 | ||
| Membrane repair defects in muscular dystrophy are linked to altered interaction between MG53, caveolin-3, and dysferlin | Q28241932 | ||
| Otoferlin, defective in a human deafness form, is essential for exocytosis at the auditory ribbon synapse | Q28269823 | ||
| Annexin A1 and glucocorticoids as effectors of the resolution of inflammation | Q28304897 | ||
| MG53 regulates membrane budding and exocytosis in muscle cells. | Q28507432 | ||
| Impaired membrane resealing and autoimmune myositis in synaptotagmin VII-deficient mice | Q28511824 | ||
| MG53 nucleates assembly of cell membrane repair machinery. | Q28511885 | ||
| Nonmuscle myosin IIA and IIB have distinct functions in the exocytosis-dependent process of cell membrane repair | Q28512682 | ||
| Plasma membrane repair is mediated by Ca(2+)-regulated exocytosis of lysosomes | Q28572060 | ||
| Membrane wounding triggers ATP release and dysferlin-mediated intercellular calcium signaling | Q28752070 | ||
| Tolerance, danger, and the extended family | Q29547532 | ||
| How dying cells alert the immune system to danger | Q29615501 | ||
| Molecular identification of a danger signal that alerts the immune system to dying cells | Q29619497 | ||
| AHNAK-mediated activation of phospholipase C-gamma1 through protein kinase C. | Q30829579 | ||
| The endomembrane requirement for cell surface repair | Q30910745 | ||
| Effects of rituximab in two patients with dysferlin-deficient muscular dystrophy | Q30985481 | ||
| Dysferlin and the plasma membrane repair in muscular dystrophy | Q33201061 | ||
| Calpain is required for the rapid, calcium-dependent repair of wounded plasma membrane | Q33264425 | ||
| Calcium-dependent plasma membrane repair requires m- or mu-calpain, but not calpain-3, the proteasome, or caspases | Q33506801 | ||
| Dysferlin interacts with tubulin and microtubules in mouse skeletal muscle | Q33559890 | ||
| Cardioprotection of ischemia/reperfusion injury by cholesterol-dependent MG53-mediated membrane repair | Q33577773 | ||
| Extensive mononuclear infiltration and myogenesis characterize recovery of dysferlin-null skeletal muscle from contraction-induced injuries | Q33655550 | ||
| A plasma membrane wound proteome: reversible externalization of intracellular proteins following reparable mechanical damage | Q33681733 | ||
| Proteomic analysis of the dysferlin protein complex unveils its importance for sarcolemmal maintenance and integrity | Q33747737 | ||
| Natural adjuvants: endogenous activators of dendritic cells | Q33878894 | ||
| Inflammasome up-regulation and activation in dysferlin-deficient skeletal muscle | Q33882512 | ||
| Otoferlin is a calcium sensor that directly regulates SNARE-mediated membrane fusion | Q34191602 | ||
| Complement-targeted therapeutics | Q34255011 | ||
| Genetic ablation of complement C3 attenuates muscle pathology in dysferlin-deficient mice | Q34360151 | ||
| Membrane repair and immunological danger. | Q34360555 | ||
| A New Role for the Muscle Repair Protein Dysferlin in Endothelial Cell Adhesion and Angiogenesis | Q34374864 | ||
| Dysferlin interacts with affixin (beta-parvin) at the sarcolemma | Q34412011 | ||
| Requirement for annexin A1 in plasma membrane repair | Q34652881 | ||
| Phenotypic study in 40 patients with dysferlin gene mutations: high frequency of atypical phenotypes | Q34663171 | ||
| Clarifying the boundaries between the inflammatory and dystrophic myopathies: insights from molecular diagnostics and microarrays. | Q35036168 | ||
| Repairing the tears: dysferlin in muscle membrane repair | Q35203020 | ||
| Myocardial ischaemia and the inflammatory response: release of heat shock protein 70 after myocardial infarction | Q35583741 | ||
| Dysferlin-mediated membrane repair protects the heart from stress-induced left ventricular injury | Q35865366 | ||
| Natural endogenous adjuvants. | Q35988793 | ||
| An emergency response team for membrane repair | Q36146942 | ||
| Calcium-regulated exocytosis is required for cell membrane resealing | Q36236314 | ||
| Vesicle accumulation and exocytosis at sites of plasma membrane disruption | Q36236320 | ||
| Kinesin- and myosin-driven steps of vesicle recruitment for Ca2+-regulated exocytosis. | Q36263570 | ||
| Dysferlin and muscle membrane repair. | Q36282549 | ||
| Dysferlin deficiency enhances monocyte phagocytosis: a model for the inflammatory onset of limb-girdle muscular dystrophy 2B. | Q36482213 | ||
| Dysferlin in membrane trafficking and patch repair. | Q36839858 | ||
| Annexin-A1: a pivotal regulator of the innate and adaptive immune systems | Q36882549 | ||
| Impaired recovery of dysferlin-null skeletal muscle after contraction-induced injury in vivo | Q37143811 | ||
| Attenuated muscle regeneration is a key factor in dysferlin-deficient muscular dystrophy | Q37183967 | ||
| Cell wounding and repair in ventilator injured lungs | Q37220652 | ||
| Mycobacterium tuberculosis evades macrophage defenses by inhibiting plasma membrane repair | Q37314284 | ||
| Genetic manipulation of dysferlin expression in skeletal muscle: novel insights into muscular dystrophy | Q37413634 | ||
| Heat shock protein 70 is a potent activator of the human complement system. | Q37489832 | ||
| Complement membrane attack on nucleated cells: resistance, recovery and non-lethal effects | Q38747540 | ||
| From T-tubule to sarcolemma: damage-induced dysferlin translocation in early myogenesis | Q40158281 | ||
| Cell death releases endogenous adjuvants that selectively enhance immune surveillance of particulate antigens | Q40761219 | ||
| Synaptotagmins: C2-domain proteins that regulate membrane traffic | Q41118335 | ||
| The earliest pathologic alterations in dysferlinopathy | Q42505709 | ||
| Mitsugumin 53 (MG53) facilitates vesicle trafficking in striated muscle to contribute to cell membrane repair | Q42605988 | ||
| Torn apart: membrane rupture in muscular dystrophies and associated cardiomyopathies | Q42734888 | ||
| Cell membrane resealing by a vesicular mechanism similar to neurotransmitter release | Q42802526 | ||
| Molecular regulation of membrane resealing in 3T3 fibroblasts. | Q42823718 | ||
| Inflammation in dysferlin myopathy: immunohistochemical characterization of 13 patients. | Q43820156 | ||
| Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway | Q44539124 | ||
| Plasmalemmal sealing of transected mammalian neurites is a gradual process mediated by Ca(2+)-regulated proteins. | Q44642546 | ||
| Effects of HMGB1 on in vitro responses of isolated muscle fibers and functional aspects in skeletal muscles of idiopathic inflammatory myopathies | Q44755630 | ||
| Complement and complement inhibitors: their role in autoimmune and inflammatory diseases | Q45275069 | ||
| AHNAK, a protein that binds and activates phospholipase C-gamma1 in the presence of arachidonic acid | Q47966265 | ||
| Calcium-dependent freezing tolerance in Arabidopsis involves membrane resealing via synaptotagmin SYT1. | Q48071856 | ||
| Dysferlin is a new marker for leaky brain blood vessels in multiple sclerosis. | Q48427400 | ||
| Live cell imaging of outward and inward vesiculation induced by the complement c5b-9 complex. | Q50687414 | ||
| Calcium dependence of membrane sealing at the cut end of the cockroach giant axon. | Q52467292 | ||
| Increased susceptibility to complement attack due to down-regulation of decay-accelerating factor/CD55 in dysferlin-deficient muscular dystrophy. | Q52936188 | ||
| Role of thrombospondin 1 in macrophage inflammation in dysferlin myopathy. | Q54428202 | ||
| Arabidopsis synaptotagmin 1 is required for the maintenance of plasma membrane integrity and cell viability. | Q54502571 | ||
| Dysferlin associates with the developing T-tubule system in rodent and human skeletal muscle | Q57390058 | ||
| Muscle inflammation, autoimmune Addison's disease and sarcoidosis in a patient with dysferlin deficiency | Q59876077 | ||
| PLA2 promotes fusion between PMN-specific granules and complex liposomes | Q71131918 | ||
| How a nerve fiber repairs its cut end: involvement of phospholipase A2 | Q71155817 | ||
| Axolemmal repair requires proteins that mediate synaptic vesicle fusion | Q74182014 | ||
| Muscle pathology in dysferlin deficiency | Q78553616 | ||
| Complementary therapies for inflammation | Q79222441 | ||
| Intracellular localization of dysferlin and its association with the dihydropyridine receptor | Q82898570 | ||
| Membrane repair redux: redox of MG53 | Q83144922 | ||
| MG53 constitutes a primary determinant of cardiac ischemic preconditioning | Q84338697 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 10 | |
| P577 | publication date | 2011-03-01 | |
| P1433 | published in | Skeletal Muscle | Q27723741 |
| P1476 | title | Muscle membrane repair and inflammatory attack in dysferlinopathy | |
| P478 | volume | 1 |
| Q38828599 | A fragmented form of annexin A1 is secreted from C2C12 myotubes by electric pulse-induced contraction |
| Q36108522 | A novel perspective for burn-induced myopathy: Membrane repair defect |
| Q44985983 | Acute failure of action potential conduction in mdx muscle reveals new mechanism of contraction-induced force loss. |
| Q36309877 | Acute heat stress prior to downhill running may enhance skeletal muscle remodeling |
| Q51089580 | Annexin A2 links poor myofiber repair with inflammation and adipogenic replacement of the injured muscle. |
| Q35632288 | CD4+ cells, macrophages, MHC-I and C5b-9 involve the pathogenesis of dysferlinopathy |
| Q34497771 | Caveolae protect endothelial cells from membrane rupture during increased cardiac output |
| Q35637260 | Characterization of a novel chicken muscle disorder through differential gene expression and pathway analysis using RNA-sequencing |
| Q27022016 | Damage control: cellular mechanisms of plasma membrane repair |
| Q36085192 | Dysferlin and animal models for dysferlinopathy |
| Q30582564 | Dysferlin regulates cell membrane repair by facilitating injury-triggered acid sphingomyelinase secretion. |
| Q38092854 | Dysferlin-deficient muscular dystrophy and innate immune activation. |
| Q36131039 | Dysferlinopathy in Switzerland: clinical phenotypes and potential founder effects |
| Q33878140 | Expression levels of sarcolemmal membrane repair proteins following prolonged exercise training in mice |
| Q35859252 | Heterogeneous characteristics of Korean patients with dysferlinopathy |
| Q34094843 | Limb-girdle muscular dystrophy subtypes: First-reported cohort from northeastern China |
| Q86291937 | Muscular dystrophies |
| Q91594164 | Muscular dystrophies |
| Q30596300 | Myofiber HLA-DR expression is a distinctive biomarker for antisynthetase-associated myopathy |
| Q34103354 | Myogenesis in dysferlin-deficient myoblasts is inhibited by an intrinsic inflammatory response |
| Q38075201 | Oxidative stress and pathology in muscular dystrophies: focus on protein thiol oxidation and dysferlinopathies. |
| Q100696231 | PTEN Inhibition Ameliorates Muscle Degeneration and Improves Muscle Function in a Mouse Model of Duchenne Muscular Dystrophy |
| Q38921880 | Progress and challenges in diagnosis of dysferlinopathy |
| Q28306546 | Quantitation of the calcium and membrane binding properties of the C2 domains of dysferlin |
| Q36096978 | Skeletal muscle interleukin 15 promotes CD8(+) T-cell function and autoimmune myositis |
| Q90029822 | Structural Basis for the Distinct Membrane Binding Activity of the Homologous C2A Domains of Myoferlin and Dysferlin |
| Q34201280 | TRIM72 is required for effective repair of alveolar epithelial cell wounding. |
| Q36031274 | The absence of dysferlin induces the expression of functional connexin-based hemichannels in human myotubes |
| Q33808490 | The effects of MyD88 deficiency on disease phenotype in dysferlin-deficient A/J mice: role of endogenous TLR ligands. |
| Q35949413 | The mdx Mutation in the 129/Sv Background Results in a Milder Phenotype: Transcriptome Comparative Analysis Searching for the Protective Factors |
| Q28076877 | The role of oxidative stress in skeletal muscle injury and regeneration: focus on antioxidant enzymes |
| Q50066457 | Thrombospondin-1 and disease progression in dysferlinopathy. |
| Q91811599 | Truncating Variant in Myof Gene Is Associated With Limb-Girdle Type Muscular Dystrophy and Cardiomyopathy |
| Q35923265 | Upregulated IL-1β in dysferlin-deficient muscle attenuates regeneration by blunting the response to pro-inflammatory macrophages |
Search more.